May 21, 2021 Comments Off on New patent for Neurocrine drug INGREZZA Posted in: Patent Added Annual Drug Patent Expirations for INGREZZA Ingrezza is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier. There are fifteen patents protecting…
The post New patent for Neurocrine drug INGREZZA appeared first o…
May 21, 2021 Comments Off on Which pharmaceutical companies have the most drug patents in Luxembourg? Posted in: Infographic This chart shows the pharmaceutical companies with the most patents in Luxembourg. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug p…